Add to Cart View Cart/Checkout More Products

Volume 5, 2001 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2001 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 5 No. 1 January/February 2001 Compounding for Pediatric Patients
Vol. 5 No. 2 March/April 2001 Compounding for Animals
Vol. 5 No. 3 May/June 2001 The Business of Compounding
Vol. 5 No. 4 July/August 2001 Sterile Product Compounding
Vol. 5 No. 5 September/October 2001 Bioidentical Hormone Replacement Therapy
Vol. 5 No. 6 November/December 2001 High-Tech Compounding

Articles
Volume/IssuePageTitle
Vol. 5 No. 1 6 Pediatric Compounding: Coloring Outside the Lines
Vol. 5 No. 1 9 Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Vol. 5 No. 1 13 Flavoring: Compounding a Treat
Vol. 5 No. 1 18 Autism in Children
Vol. 5 No. 1 21 Methylphenidate in the Treatment of Attention Deficit Disorders
Vol. 5 No. 1 23 A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature
Vol. 5 No. 1 25 Book Reviews: Stability and Formulation References
Vol. 5 No. 1 28 Glycopyrrolate 1% Cream
Vol. 5 No. 1 28 Topical Therapy for Localized Hyperhidrosis
Vol. 5 No. 1 29 Methenamine 5% Lotion
Vol. 5 No. 1 30 Compounding in History: Pediatric Considerations
Vol. 5 No. 1 32 Profile of a Practice
Vol. 5 No. 1 36 The Basics of Compounding Powders and Granules
Vol. 5 No. 1 38 Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Vol. 5 No. 1 38 Menthol Dusting Powder-Example of Powder Formulations
Vol. 5 No. 1 42 Cholestyramine 6.5% Ointment
Vol. 5 No. 1 43 Ivermectin 0.8% Creme Rinse
Vol. 5 No. 1 44 Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Vol. 5 No. 1 45 Lorazepam 1-mg Chewable Gummy Gels
Vol. 5 No. 1 46 Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Vol. 5 No. 1 47 Milk of Magnesia Concentrate, Unflavored
Vol. 5 No. 1 48 Natural Head Lice Repellant Spray
Vol. 5 No. 1 49 Niacinamide 4% Acne Gel
Vol. 5 No. 1 50 Poison Ivy Gel with 1% Hydrocortisone
Vol. 5 No. 1 51 Promethazine HCl 50-mg/mL in PLO Gel
Vol. 5 No. 1 52 Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Vol. 5 No. 1 55 Rhodococcus Equi Pneumonia in Foals
Vol. 5 No. 1 59 Sterile-Product Preparations: Mix or Buy?
Vol. 5 No. 1 65 Oral Liquid Vehicles, Featured Excipient:
Vol. 5 No. 1 67 Purchasing Chemicals for Pharmaceutical Compounding
Vol. 5 No. 1 69 Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Vol. 5 No. 1 73 Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 5 No. 1 75 Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 5 No. 1 78 Calculations
Vol. 5 No. 2 86 Psychoactive Agents in Veterinary Medicine, The Use of
Vol. 5 No. 2 89 Benzoate or Not to Benzoate: Cats Are the Question, To
Vol. 5 No. 2 92 Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Vol. 5 No. 2 95 Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Vol. 5 No. 2 97 Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding
Vol. 5 No. 2 101 Drugs Banned for Use in Food Animals: An Explanation
Vol. 5 No. 2 104 A Simplified Guide to Veterinary Compounding
Vol. 5 No. 2 106 Equipment for Large-Volume Aseptic Veterinary Compounding
Vol. 5 No. 2 107 Compounded Injectables for Veterinary Use
Vol. 5 No. 2 108 Book Reviews: Veterinary Compounding
Vol. 5 No. 2 112 From Wagon-Era Paregoric to Computer-Era Herbals
Vol. 5 No. 2 116 Wish You Were Here: The Niagara Apothecary
Vol. 5 No. 2 118 Profile of a Practice: Custom Rx Compounding and Natural Pharmacy
Vol. 5 No. 2 120 The Basics of Compounding Emulsions, Part 1
Vol. 5 No. 2 126 Diazoxide 50-mg/mL Suspension, Veterinary
Vol. 5 No. 2 127 Dimethyl Sulfoxide 50% Cream, Veterinary
Vol. 5 No. 2 128 EDTA-TRIS Otic Solution V-2 (Veterinary)
Vol. 5 No. 2 129 Flea Bite Gel
Vol. 5 No. 2 130 Gentamicin, Polymyxin, Neomycin, and Hydrocortisone Otic Drops
Vol. 5 No. 2 131 Iodine 2% in Oil Injection
Vol. 5 No. 2 132 Methimazole 5-mg/0.1-mL in Pluronic Lecithin Organogel
Vol. 5 No. 2 133 Sucrose Octaacetate and Capsicum Spray for Pets
Vol. 5 No. 2 134 Veterinary Antiseptic Emollient
Vol. 5 No. 2 135 Veterinary Oral Pastes
Vol. 5 No. 2 136 Infertility Care and the Role of the Compounding Pharmacist
Vol. 5 No. 2 140 Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing
Vol. 5 No. 2 145 Ointment Vehicles, Featured Excipient:
Vol. 5 No. 2 147 Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding
Vol. 5 No. 2 148 Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes
Vol. 5 No. 2 151 Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 5 No. 2 153 Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Vol. 5 No. 2 157 Calculations
Vol. 5 No. 2 160 PostScription: Case Reports and Formulations, George Roentsch, RPh.
Vol. 5 No. 2 160 Piracetam 100-mg, Ergoloid Mesylates 6-mg, and Selegiline 2.5-mg/0.2-mL Gel ("Brain Gel")
Vol. 5 No. 2 160 Oxytetracycline 15-mg/0.1-mL TD Cream
Vol. 5 No. 3 166 Motivation and Management: How to Build Your Business into the Job You Love
Vol. 5 No. 3 170 A New Trend in Pharmacy Practice: Private Consultations
Vol. 5 No. 3 174 Formulations for Success in Compounding, Part 1
Vol. 5 No. 3 176 Developing a Business Plan for a Compounding Specialty Pharmacy
Vol. 5 No. 3 180 Pricing Strategies
Vol. 5 No. 3 182 The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees
Vol. 5 No. 3 185 Book Reviews: Business Topics for Compounding Pharmacists
Vol. 5 No. 3 187 Software for the Compounding Pharmacist: A Review
Vol. 5 No. 3 192 Capsule-Weighing and Trituration Calculations
Vol. 5 No. 3 195 Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study
Vol. 5 No. 3 196 Compounding in History: Compounding Economics
Vol. 5 No. 3 197 Stoughton's Bitters
Vol. 5 No. 3 197 Tinctura Kino Composita
Vol. 5 No. 3 198 The Basics of Compounding Emulsions, Part 2
Vol. 5 No. 3 201 Dry Skin and Massage Lotion-Example
Vol. 5 No. 3 204 Amphotericin 5-mg/mL Nasal Inhalation
Vol. 5 No. 3 205 Anthralin 1% in Lipid Crystals Cream
Vol. 5 No. 3 206 Bifonazol 1% and Urea 40% in White Petrolatum
Vol. 5 No. 3 207 Hand Cream, Protective
Vol. 5 No. 3 208 Idoxuridine 15% in Dimethyl Sulfoxide (DMSO)
Vol. 5 No. 3 209 Mitomycin 0.02% Ophthalmic Solution
Vol. 5 No. 3 210 Phenytoin 100- to 400-mg Rectal Suppositories
Vol. 5 No. 3 211 Tacrolimus 0.3% Ointment
Vol. 5 No. 3 212 Tetracycline HCl 1% Ophthalmic Ointment
Vol. 5 No. 3 213 Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Vol. 5 No. 3 214 Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Vol. 5 No. 3 216 The American Veterinary Medical Association Compounding Position Statement
Vol. 5 No. 3 218 Natural Progesterone in Natural Hormone Replacement Therapy, The Role of
Vol. 5 No. 3 221 Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective
Vol. 5 No. 3 226 Establishing and Maintaining a Compounding Pharmacy Reference Library
Vol. 5 No. 3 228 Official Water-Repelling Agents: The Official Silicones, Featured Excipient:
Vol. 5 No. 3 229 Calculations
Vol. 5 No. 3 230 Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 5 No. 3 232 Stability of Oral Liquid Dosage Forms of Ethacrynic Acid
Vol. 5 No. 3 234 Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories
Vol. 5 No. 3 240 PostScription: Compounding Pharmacists
Vol. 5 No. 4 246 Quality Assurance for Sterile Products
Vol. 5 No. 4 254 Sterile Compounding with Barrier-Isolation Technology
Vol. 5 No. 4 259 Bacterial Endotoxins and Pyrogens
Vol. 5 No. 4 265 Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"
Vol. 5 No. 4 268 Antineoplastic Agents
Vol. 5 No. 4 273 Compounding Issues and Accreditation Agencies
Vol. 5 No. 4 275 Book Reviews
Vol. 5 No. 4 278 Sterile Compounding: Excerpts from the Reviews of Current Published Literature
Vol. 5 No. 4 282 Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Vol. 5 No. 4 284 Analytical Testing Facilities and Products
Vol. 5 No. 4 287 Formulations for Success, Part 2
Vol. 5 No. 4 290 Wish You Were Here: The Stabler-Leadbeater Apothecary Museum
Vol. 5 No. 4 294 Basics of Compounding: Suspensions
Vol. 5 No. 4 296 Suspension Structured Vehicle, USP
Vol. 5 No. 4 296 Sugar-Free Suspension Structured Vehicle, USP
Vol. 5 No. 4 297 Spironolactone Oral Suspension 2-mg/mL
Vol. 5 No. 4 297 Progesterone Oral Suspension 40-mg/mL
Vol. 5 No. 4 297 Progesterone Enema 200-mg/mL
Vol. 5 No. 4 297 Xanthan Gum Oral Suspension Vehicle 0.3%
Vol. 5 No. 4 297 Wound Care Mixture
Vol. 5 No. 4 300 Cefazolin Ophthalmic Solution, USP 0.35- mg/mL
Vol. 5 No. 4 301 Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Vol. 5 No. 4 302 Fibrin Glue
Vol. 5 No. 4 303 Hyaluronidase Injection
Vol. 5 No. 4 304 Hypertonic Sodium Chloride 20% Sclerotherapy Injections
Vol. 5 No. 4 305 Metronidazole and Neomycin Sulfate Irrigation Solution
Vol. 5 No. 4 306 Pediatric Preoperative Cocktail Injection
Vol. 5 No. 4 307 Phenylephrine 0.25% Ophthalmic Solution, Preservative Free
Vol. 5 No. 4 308 Sclerotherapy Injections of Phenol for Pain Management
Vol. 5 No. 4 309 Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution
Vol. 5 No. 4 310 Wetting and/or Solubilizing Agents, Featured Excipient:
Vol. 5 No. 4 313 Maintenance of the Cleanroom
Vol. 5 No. 4 314 Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Vol. 5 No. 4 320 A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes
Vol. 5 No. 4 323 Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Vol. 5 No. 4 325 Calculations
Vol. 5 No. 4 328 PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor
Vol. 5 No. 5 332 Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want
Vol. 5 No. 5 336 Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Vol. 5 No. 5 339 Bioidentical Hormones in the Treatment of Osteoporosis
Vol. 5 No. 5 342 The Value of Hormone Assessment
Vol. 5 No. 5 346 Estrogen Replacement: A Review of Current Literature
Vol. 5 No. 5 351 Treating Andropause: Prohormones and Hormone Metabolic Modifiers
Vol. 5 No. 5 354 Bioidentical Topical Progesterone: A Survey of Patients
Vol. 5 No. 5 356 Book Reviews: Hormone Replacement Therapy
Vol. 5 No. 5 360 Charting Systems: Organizing Information Effectively
Vol. 5 No. 5 362 Minimizing the Risk of Cholesterol-Lowering Therapy
Vol. 5 No. 5 365 Compounding in History: Treatment at the Change of Life
Vol. 5 No. 5 366 Flush Powder, No. 2
Vol. 5 No. 5 366 Tincture of Black Cohosh
Vol. 5 No. 5 366 Lydia Pinkham's Vegetable Compound
Vol. 5 No. 5 369 The Basics of Compounding: Tablets and Pills
Vol. 5 No. 5 374 Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO)
Vol. 5 No. 5 375 Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream
Vol. 5 No. 5 376 Libido Cream
Vol. 5 No. 5 377 Progesterone 50-mg/mL Clear Topical Solution
Vol. 5 No. 5 378 Progesterone Low-Potency 0.0065% Topical Cream
Vol. 5 No. 5 379 Sildenafil 1% Topical Cream
Vol. 5 No. 5 380 Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO)
Vol. 5 No. 5 381 Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Vol. 5 No. 5 382 Testosterone 25-mg/mL Clear Solution
Vol. 5 No. 5 383 Testosterone 2% Scalp Lotion
Vol. 5 No. 5 384 Compounding Containment Devices: Buyer Be Aware
Vol. 5 No. 5 389 Capsule and Tablet Disintegrating Agents, Featured Excipient:
Vol. 5 No. 5 391 Calculations
Vol. 5 No. 5 392 Developing a Capsule Formulation
Vol. 5 No. 5 394 Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes
Vol. 5 No. 5 397 Assessment of the Stability of Teicoplanin in Intravenous Infusions
Vol. 5 No. 5 401 Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Vol. 5 No. 5 408 PostScription: Compounding Errors: Lessons Learned, Never To Be Forgotten
Vol. 5 No. 6 412 High-tech Compounding: State-of-the-art Equipment Improves Products and Profit
Vol. 5 No. 6 419 High-tech Rx Compliance
Vol. 5 No. 6 420 High-tech Marketing Techniques
Vol. 5 No. 6 422 Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures
Vol. 5 No. 6 424 Nanotechnology: The Ultimate Alchemy
Vol. 5 No. 6 426 Future Trends in High-technology Pharmacy Compounding
Vol. 5 No. 6 427 Using Technology to Enhance the Practice of Pharmacy
Vol. 5 No. 6 430 Tips for Preventing Viruses…
Vol. 5 No. 6 436 Topical Secretin for the Treatment of Autism
Vol. 5 No. 6 438 Wish You Were Here: Vienna, Austria
Vol. 5 No. 6 441 Basics of Compounding: Parenteral Preparations
Vol. 5 No. 6 450 Acetic Acid 5% Iontophoresis Solution
Vol. 5 No. 6 451 Ceftazidime 20-mg/mL for Ambulatory Infusion Pump
Vol. 5 No. 6 452 Dexamethasone, Lidocaine, and Verapamil Iontophoresis Solutions for Peyronie's Disease
Vol. 5 No. 6 453 Doxycycline Hyclate 200-mg/mL Avian Injection
Vol. 5 No. 6 454 Hydrocortisone 10% Phonophoresis Gel
Vol. 5 No. 6 455 Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution
Vol. 5 No. 6 456 Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion
Vol. 5 No. 6 457 Tobramycin-impregnated Polymethylmethacrylate Beads
Vol. 5 No. 6 458 Total Parenteral Nutrition Solution
Vol. 5 No. 6 459 Vancomycin 5-mg Sponge Disks
Vol. 5 No. 6 460 Hormone Replacement Therapy, Part 2: Estrogen Defined
Vol. 5 No. 6 462 The Science Behind Hormone Replacement Therapy, Part 1
Vol. 5 No. 6 465 New Perspectives on Vancomycin Use in Home Care, Part 1
Vol. 5 No. 6 471 Tablet and Lozenge Binders, Featured Excipient:
Vol. 5 No. 6 474 Training Personnel
Vol. 5 No. 6 476 Cross-contamination in Porcelain Mortars
Vol. 5 No. 6 480 Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Vol. 5 No. 6 482 Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes
Vol. 5 No. 6 485 Calculations
Vol. 5 No. 6 488 PostScription: Lifelong Learning + Technology = Valuable Tools for the Compounding Pharmacist